The use of antipsychotic drugs to treat conditions ... slow movement and involuntary tremors (known as extrapyramidal symptoms, some of which can be permanent), substantial weight gain, an ...

Background: Second-generation antipsychotics (SGAs) are thought to have a lower likelihood of inducing extrapyramidal symptoms (EPS) than are first-generation antipsychotics (FGAs). Clinical ...

OPC-4392 was shown to be effective against negative symptoms and showed no propensity to induce extrapyramidal symptoms ... characteristics of other atypical antipsychotics with respect to ...

Extrapyramidal movement abnormalities were quickly recognized as a universal adverse effect of the first-generation medicines. Clozapine, the most efficacious antipsychotic agent, was developed ...

Summary: Risperidone is the first atypical antipsychotic available in a long ... is similar to that found with oral treatment. Extrapyramidal symptom ratings have shown improvement from baseline ...

antipsychotics. They are less likely to cause involuntary movements (extrapyramidal effects), but many may cause weight gain and increased cholesterol. However, these effects were not common with ...